limitations of current treatments

  • The bioavailability of oral diuretics can be unpredictable, especially in the presence of gut edema1,2

  • Symptoms of fluid overload can continue or worsen even if oral therapy is changed or augmented3

  • In a study of patients who presented to the emergency department with worsening congestion despite oral diuretic therapy, 46% were receiving torsemide or bumetanide4

  • While IV loop diuretics can avoid these challenges, their administration often necessitates hospitalization3

Oral diuretics are prevented from being successfully absorbed into edematous GI mucosa

intervention is possible before symptoms escalate

As fluid overload symptoms increase, patient health-related quality of life decreases. There is a window of opportunity for intervention with a highly bioavailable outpatient diuretic before IV diuretics are needed.

*

Kansas City Cardiomyopathy Questionnaire-12 overall summary scores, including quality of life assessment, were related to congestive signs and symptoms (partial R2 0.32).

GI=gastrointestinal; HRQOL=health-related quality of life; IV=intravenous.

make a plan for FUROSCIX

FUROSCIX ReadyFlow™ is the only outpatient diuretic that can provide complete bioavailability with administration in seconds. Integrating FUROSCIX into your outpatient treatment plan for your HF and CKD patients should start now.

Learn More